CTLA4 and neoplasm: When co-cultured with either 90Y-NM600-treated MOC2 or 90Y-NM600-treated B16 cells, both CD4+ T cells and CD8+ T cells demonstrated significantly increased expression of CTLA-4, as compared to those co-cultured with untreated control tumor cells (Figure 8H-I).